These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 8516853

  • 1. Outcome of live-related donor renal transplants in their second decade.
    Georgi BA, Cacciarelli TV, Sumrani N, Goldberg K, Hong JH, Sommer BG.
    Transplant Proc; 1993 Jun; 25(3):2164-5. PubMed ID: 8516853
    [No Abstract] [Full Text] [Related]

  • 2. Posttransplant serum creatinine area under the curve predicts renal allograft outcome.
    Sumrani N, Hong J, Miles A, Markell M, Distant D, Fleishhacker J, Maursky V, Jean-Baptiste F, Sommer B.
    Transplant Proc; 1996 Feb; 28(1):356-7. PubMed ID: 8644260
    [No Abstract] [Full Text] [Related]

  • 3. Early or delayed use of cyclosporine in HLA-mismatched living-related donor renal transplants.
    Sumrani N, Hong JH, Daskalakis P, Cacciarelli TV, Markell MS, Sommer BG.
    Transplant Proc; 1993 Jun; 25(3):2246-7. PubMed ID: 8516888
    [No Abstract] [Full Text] [Related]

  • 4. Does acute tubular necrosis affect renal transplant outcome? The impact of rejection episodes.
    Troppmann C, Almond PS, Payne WD, Dunn DL, Gores PF, Gruessner RW, Sutherland DE, Matas AJ, Najarian JS.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):905. PubMed ID: 8442263
    [No Abstract] [Full Text] [Related]

  • 5. Donor-specific transfusion in living-related renal transplants.
    Basri N, Nezamuddin N, Aman H, Banqash H, Sharwani N.
    Transplant Proc; 1992 Oct; 24(5):1746. PubMed ID: 1412822
    [No Abstract] [Full Text] [Related]

  • 6. Cyclosporine levels impact early rejection episodes.
    Granger DK, Amin NB, Sorenson AL, Gillingham KJ, Canafax DM, Matas AJ.
    Transplant Proc; 1994 Oct; 26(5):2513. PubMed ID: 7940771
    [No Abstract] [Full Text] [Related]

  • 7. Donor-specific transfusion in living related and unrelated donor kidney transplantation: minimal sensitization and excellent graft outcome.
    Kong JM, Jeong JH, Kang JK, Seong IG, Kim BC.
    Transplant Proc; 1995 Feb; 27(1):1036-7. PubMed ID: 7878792
    [No Abstract] [Full Text] [Related]

  • 8. Triple drug therapy in haploidentical living related and cadaveric kidney transplantation.
    Diliz-Pérez H, Alvarez L, Zúñiga V, Estefan J, Mares J, Cerda L, Luque E, Carrera B, Volkow P, Martínez R.
    Transplant Proc; 1991 Apr; 23(2):1747-8. PubMed ID: 2053142
    [No Abstract] [Full Text] [Related]

  • 9. Cyclosporin monotherapy in pancreaticorenal transplantation.
    Ward RG, Gecim E, Bone JM, Bakran A, Sells RA.
    Transplant Proc; 1994 Apr; 26(2):548. PubMed ID: 8171547
    [No Abstract] [Full Text] [Related]

  • 10. ATG in steroid-resistant acute rejection in living related kidney transplantation: long-term evaluation.
    Bakr MA, Foda MA, Sally S, Sobh MA, Ghoneim MA.
    Transplant Proc; 1994 Dec; 26(6):3161-2. PubMed ID: 7998103
    [No Abstract] [Full Text] [Related]

  • 11. Renal transplantation in cyclosporine-treated patients over age 50.
    Riera L, Serón D, Castelao AM, Griñó JM, Franco E, Bover J, Vigués L, Alsina J, Serrallach N.
    Transplant Proc; 1992 Feb; 24(1):122-3. PubMed ID: 1539204
    [No Abstract] [Full Text] [Related]

  • 12. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N, Hong JH, DiBenedetto A, Clayton R, Miles AM, Markell MS, Distant DA, Fleishhacker J, Sommer BG.
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract] [Full Text] [Related]

  • 13. Predictors of improved outcome in second pediatric renal transplant recipients.
    Moss A, Almond PS, Matas AJ, Gillingham K, Najarian JS.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):597. PubMed ID: 8438429
    [No Abstract] [Full Text] [Related]

  • 14. Chagas disease and transplantation.
    Vazquez MC, Sabbatiello R, Schiavelli R, Maiolo E, Jacob N, Pattin M, Rearte A.
    Transplant Proc; 1996 Dec; 28(6):3301-3. PubMed ID: 8962281
    [No Abstract] [Full Text] [Related]

  • 15. Cytomegalovirus infection in pediatric heart transplantation.
    Fukushima N, Gundry SR, Razzouk AJ, Bailey LL.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1423-5. PubMed ID: 8382868
    [No Abstract] [Full Text] [Related]

  • 16. OKT3 for steroid-resistant renal allograft rejection: differential response in adults and children.
    Shmueli D, Nakache R, Lustig S, Bar Nathan N, Yussim A, Shaharabani E, Geier A, Shapira Z.
    Transplant Proc; 1994 Aug; 26(4):1948-9. PubMed ID: 8066630
    [No Abstract] [Full Text] [Related]

  • 17. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG, Henry ML, Ferguson RM.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
    [No Abstract] [Full Text] [Related]

  • 18. Clinical use of rabbit antihuman lymphocyte globulin in cadaver-kidney transplantation.
    Mannick JA, Davis RC, Cooperband SR, Glasgow AH, Williams LF, Harrington JT, Cavallo T, Schmitt GW, Idelson BA, Olsson CA, Nabseth DC.
    N Engl J Med; 1971 May 20; 284(20):1109-15. PubMed ID: 4928659
    [No Abstract] [Full Text] [Related]

  • 19. Effect of donor age on outcome of living related kidney transplantation.
    Kim YL, Kim JH, Kwon TH, Cho DK, Kim YW, Chang SI, Chung SK, Chang SK.
    Transplant Proc; 1996 Jun 20; 28(3):1580-1. PubMed ID: 8658793
    [No Abstract] [Full Text] [Related]

  • 20. Serum erythropoietin and parathyroid hormone concentrations in kidney transplant patients during acute graft rejection.
    Kokot F, Wiecek A, Grzeszczak W, Lao M, Kuśmierski S, Cierpka L, Gradowska L, Jagiełło R.
    Transplant Proc; 1996 Dec 20; 28(6):3477-9. PubMed ID: 8962352
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.